Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Dynamic microbial populations along the Cuyahoga River.

Cannon MV, Craine J, Hester J, Shalkhauser A, Chan ER, Logue K, Small S, Serre D.

PLoS One. 2017 Oct 19;12(10):e0186290. doi: 10.1371/journal.pone.0186290. eCollection 2017.

2.

Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study.

Trottier B, Lake JE, Logue K, Brinson C, Santiago L, Brennan C, Koteff JA, Wynne B, Hopking J, Granier C, Aboud M.

Antivir Ther. 2017;22(5):459-460. doi: 10.3851/IMP3192. Epub 2017 Sep 13. No abstract available.

PMID:
28901945
3.

Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study.

Trottier B, Lake JE, Logue K, Brinson C, Santiago L, Brennan C, Koteff JA, Wynne B, Hopking J, Granier C, Aboud M.

Antivir Ther. 2017;22(4):295-305. doi: 10.3851/IMP3166. Epub 2017 Apr 12. Erratum in: Antivir Ther. 2017;22(5):459-460.

PMID:
28401876
4.

Maternal Health Risk Assessment and Behavioral Intervention in the NICU Setting Following Very Low Birth Weight Delivery.

Dunlop AL, Logue K, Thorne C.

Matern Child Health J. 2016 Nov;20(Suppl 1):28-38.

PMID:
27562798
5.

In silico assessment of primers for eDNA studies using PrimerTree and application to characterize the biodiversity surrounding the Cuyahoga River.

Cannon MV, Hester J, Shalkhauser A, Chan ER, Logue K, Small ST, Serre D.

Sci Rep. 2016 Mar 11;6:22908. doi: 10.1038/srep22908.

6.

Unbiased Characterization of Anopheles Mosquito Blood Meals by Targeted High-Throughput Sequencing.

Logue K, Keven JB, Cannon MV, Reimer L, Siba P, Walker ED, Zimmerman PA, Serre D.

PLoS Negl Trop Dis. 2016 Mar 10;10(3):e0004512. doi: 10.1371/journal.pntd.0004512. eCollection 2016 Mar.

7.

Whole-genome sequencing reveals absence of recent gene flow and separate demographic histories for Anopheles punctulatus mosquitoes in Papua New Guinea.

Logue K, Small ST, Chan ER, Reimer L, Siba PM, Zimmerman PA, Serre D.

Mol Ecol. 2015 Mar;24(6):1263-74. doi: 10.1111/mec.13107. Epub 2015 Mar 6.

8.

The engagement of academic institutions in community disaster response: a comparative analysis.

Dunlop AL, Logue KM, Isakov AP.

Public Health Rep. 2014;129 Suppl 4:87-95.

9.

Mitochondrial genome sequences reveal deep divergences among Anopheles punctulatus sibling species in Papua New Guinea.

Logue K, Chan ER, Phipps T, Small ST, Reimer L, Henry-Halldin C, Sattabongkot J, Siba PM, Zimmerman PA, Serre D.

Malar J. 2013 Feb 14;12:64. doi: 10.1186/1475-2875-12-64.

10.

SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen.

Campo R, DeJesus E, Bredeek UF, Henry K, Khanlou H, Logue K, Brinson C, Benson P, Dau L, Wang H, White K, Flaherty J, Fralich T, Guyer B, Piontkowsky D.

Clin Infect Dis. 2013 Jun;56(11):1637-45. doi: 10.1093/cid/cis1203. Epub 2013 Jan 29. Erratum in: Clin Infect Dis. 2013 Sep;57(5):779.

11.

Acceptability and potential impact of brief preconception health risk assessment and counseling in the WIC setting.

Dunlop AL, Dretler AW, Badal HJ, Logue KM.

Am J Health Promot. 2013 Jan-Feb;27(3 Suppl):S58-65. doi: 10.4278/ajhp.120109-QUAL-7.

PMID:
23286665
12.

Change in women's knowledge of general and personal preconception health risks following targeted brief counseling in publicly funded primary care settings.

Dunlop AL, Logue KM, Thorne C, Badal HJ.

Am J Health Promot. 2013 Jan-Feb;27(3 Suppl):S50-7. doi: 10.4278/ajhp.120116-QUAN-39.

PMID:
23286664
13.

Facilitators and Barriers for Effective Academic-Community Collaboration for Disaster Preparedness and Response.

Dunlop AL, Logue KM, Vaidyanathan L, Isakov AP.

J Public Health Manag Pract. 2016 May-Jun;22(3):E20-8. doi: 10.1097/PHH.0b013e3182205087.

PMID:
23238058
14.

Role of academic institutions in community disaster response since september 11, 2001.

Dunlop AL, Logue KM, Beltran G, Isakov AP.

Disaster Med Public Health Prep. 2011 Oct;5(3):218-26. doi: 10.1001/dmp.2011.75. Review.

PMID:
22003139
15.

Preconsent education about research processes improved African Americans' willingness to participate in clinical research.

Dunlop AL, Leroy ZC, Logue KM, Glanz K, Dunlop BW.

J Clin Epidemiol. 2011 Aug;64(8):872-7. doi: 10.1016/j.jclinepi.2010.11.008. Epub 2011 Feb 17.

16.

Integrating reproductive planning with primary health care: an exploration among low-income, minority women and men.

Dunlop AL, Logue KM, Miranda MC, Narayan DA.

Sex Reprod Healthc. 2010 Apr;1(2):37-43. doi: 10.1016/j.srhc.2010.01.001. Epub 2010 Jan 25.

PMID:
21122595
17.

Functional replacement of a primary metabolic pathway via multiple independent eukaryote-to-eukaryote gene transfers and selective retention.

Nedelcu AM, Blakney AJ, Logue KD.

J Evol Biol. 2009 Sep;22(9):1882-94. doi: 10.1111/j.1420-9101.2009.01797.x. Epub 2009 Jul 9.

18.

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks.

Pulido F, Estrada V, Baril JG, Logue K, Schewe K, Plettenberg A, Duiculescu D, Yau L, Vavro C, Lim ML, Pharo C.

HIV Clin Trials. 2009 Mar-Apr;10(2):76-87. doi: 10.1310/hct1002-76.

PMID:
19487177
19.

Pregnancy-associated breast cancer.

Logue K.

Clin J Oncol Nurs. 2009 Feb;13(1):25-7. doi: 10.1188/09.CJON.25-27. No abstract available.

PMID:
19193546
20.

Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada.

Mishra S, Walmsley SL, Loutfy MR, Kaul R, Logue KJ, Gold WL.

AIDS Patient Care STDS. 2008 Mar;22(3):213-9. doi: 10.1089/apc.2007.0019.

PMID:
18290755
21.

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Lampinen TM, Chan K, Remis RS, Merid MF, Rusch M, Vincelette J, Logue K, Popovic V, Alary M, Schechter MT, Hogg RS.

CMAJ. 2005 Feb 15;172(4):479-83.

22.

Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitors.

Kaltenbach RF 3rd, Patel M, Waltermire RE, Harris GD, Stone BR, Klabe RM, Garber S, Bacheler LT, Cordova BC, Logue K, Wright MR, Erickson-Viitanen S, Trainor GL.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):605-8.

PMID:
12639540
23.

DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants.

Kaltenbach RF 3rd, Trainor G, Getman D, Harris G, Garber S, Cordova B, Bacheler L, Jeffrey S, Logue K, Cawood P, Klabe R, Diamond S, Davies M, Saye J, Jona J, Erickson-Viitanen S.

Antimicrob Agents Chemother. 2001 Nov;45(11):3021-8.

24.

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.

Bacheler L, Jeffrey S, Hanna G, D'Aquila R, Wallace L, Logue K, Cordova B, Hertogs K, Larder B, Buckery R, Baker D, Gallagher K, Scarnati H, Tritch R, Rizzo C.

J Virol. 2001 Jun;75(11):4999-5008.

25.

Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.

Corbett JW, Ko SS, Rodgers JD, Gearhart LA, Magnus NA, Bacheler LT, Diamond S, Jeffrey S, Klabe RM, Cordova BC, Garber S, Logue K, Trainor GL, Anderson PS, Erickson-Viitanen SK.

J Med Chem. 2000 May 18;43(10):2019-30.

PMID:
10821714
26.

Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.

De Lucca GV, Kim UT, Liang J, Cordova B, Klabe RM, Garber S, Bacheler LT, Lam GN, Wright MR, Logue KA, Erickson-Viitanen S, Ko SS, Trainor GL.

J Med Chem. 1998 Jun 18;41(13):2411-23.

PMID:
9632373
27.

Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysis.

Nugiel DA, Jacobs K, Cornelius L, Chang CH, Jadhav PK, Holler ER, Klabe RM, Bacheler LT, Cordova B, Garber S, Reid C, Logue KA, Gorey-Feret LJ, Lam GN, Erickson-Viitanen S, Seitz SP.

J Med Chem. 1997 May 9;40(10):1465-74.

PMID:
9154969
28.

"Health care purchaser's liability": employer's liability for the purchase of health care services.

Logue KR, Tarrant CA.

Todays OR Nurse. 1994 Sep-Oct;16(5):48-9. No abstract available.

PMID:
7974651
29.

The acquisition of taste aversions in humans with eating and drinking disorders.

Logue AW, Logue KR, Strauss KE.

Behav Res Ther. 1983;21(3):275-89. No abstract available.

PMID:
6577856

Supplemental Content

Support Center